|
COG3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.221500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.535400E-03 |
| Normal-vs-Stage2 |
7.074000E-01 |
| Normal-vs-Stage3 |
5.918000E-02 |
| Normal-vs-Stage4 |
1.296320E-02 |
| Stage1-vs-Stage2 |
2.101600E-01 |
| Stage1-vs-Stage3 |
7.701200E-01 |
| Stage1-vs-Stage4 |
7.274200E-01 |
| Stage2-vs-Stage3 |
3.090800E-01 |
| Stage2-vs-Stage4 |
2.454400E-01 |
| Stage3-vs-Stage4 |
9.090200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.223900E-03 |
| Normal-vs-AfricanAmerican |
8.450100E-02 |
| Normal-vs-Asian |
5.759700E-03 |
| Caucasian-vs-AfricanAmerican |
7.357600E-01 |
| Caucasian-vs-Asian |
7.554100E-02 |
| AfricanAmerican-vs-Asian |
8.002300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.678220E-03 |
| Normal-vs-Female |
2.080200E-01 |
| Male-vs-Female |
3.341600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.440200E-03 |
| Normal-vs-Extreme_Weight |
7.048900E-04 |
| Normal-vs-Obese |
1.411200E-01 |
| Normal-vs-Extreme_Obese |
1.291400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.578400E-01 |
| Normal_Weight-vs-Obese |
2.547400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.531400E-01 |
| Extreme_Weight-vs-Obese |
1.220010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.686400E-01 |
| Obese-vs-Extreme_Obese |
5.370400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.531960E-02 |
| Normal-vs-Age(41-60Yrs) |
3.558200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.602500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.862000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.061200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.249200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.953200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.961100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.702300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.229200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.198200E-02 |
| Normal-VS-Type2 PRCC |
6.183100E-04 |
| Normal-VS-KIRP CIMP |
1.935920E-02 |
| Normal-VS-Unclassified PRCC |
7.173000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.854400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.760100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.076000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.455800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.912000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.764000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.021300E-04 |
| Normal-vs-N1 |
4.936400E-01 |
| Normal-vs-N2 |
3.055100E-03 |
| N0-vs-N1 |
2.168200E-01 |
| N0-vs-N2 |
2.756400E-01 |
| N1-vs-N2 |
2.589600E-01 |
|
|
